Sequences

Sample result

GFP, read as protein

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

4,303 publications in 2,986 families match these filters.

  1. JP 2023523414-A2023-06-05

    CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

    GRITSTONE BIO INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  2. CONJUGATE OF FUNCTIONAL POLYPEPTIDE VARIANT, AND USE THEREOF

    PROABTECH INC

    Identity 94.5%

    Best alignment

    Query 1 to 236, hit 10 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              ||||||||||||||||||||||||||||| |||||||| |||||||||||||||||||||
    Hit    10 MSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTL 189
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||| |||||||||||||||||| ||||| |||||||||||||||
    Hit   190 VTTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLV 369
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||| ||| ||| ||||||||| ||||||| |||||||||
    Hit   370 NRIELKGIDFKEDGNILGHKLEYNFNSH*VYITADKQKNGIKANFKIRHNVEDGSVQLAD 549
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDEL 236
              ||||||||||||||||||||||||| ||||||||||||||||||||||||||||||
    Hit   550 HYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDEL 717
    

    223 of 236 identical, no gaps.

  3. US 11666641-B22023-06-06

    CRISPR nuclease

    EMENDOBIO INC.

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 2282 to 2995. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2282 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 2461
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2462 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 2641
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2642 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 2821
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   2822 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2995
    

    234 of 238 identical, no gaps.

  4. US 11667893-B22023-06-06

    Methods for establishing colorectal cancer p73 reporter gene cell line

    Guangdong Medical University

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 500 to 1213. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    500 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 679
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    680 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 859
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    860 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1039
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1040 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1213
    

    234 of 238 identical, no gaps.

  5. US 11668703-B22023-06-06

    Method for determining the level of zygosity of a seed

    LIMAGRAIN EUROPE

    Identity 97.1%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| ||||||||||||||||||||||||||||||||| |||||||||||||||||||||
    Hit   184 VTTFTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||||||| ||||||||| ||||||| |||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    231 of 238 identical, no gaps.

  6. JP 2023079849-A2023-06-08

    Adeno-associated virus analysis method based on serotype

    TOSOH corporation

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 10 to 723. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    10 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 189
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   190 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 369
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   370 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 549
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   550 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 723
    

    234 of 238 identical, no gaps.

  7. JP 2023079850-A2023-06-08

    Analysis method for adeno-associated virus

    TOSOH corporation

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 10 to 723. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    10 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 189
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   190 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 369
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   370 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 549
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   550 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 723
    

    234 of 238 identical, no gaps.

  8. JP 2023079984-A2023-06-08

    Analytical method for chimeric adeno-associated virus

    TOSOH corporation

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 10 to 723. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    10 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 189
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   190 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 369
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   370 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 549
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   550 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 723
    

    234 of 238 identical, no gaps.

  9. JP 2023523886-A2023-06-08

    NOVEL MOGROSIDE PRODUCTION SYSTEM AND METHODS

    The Coca-Cola Company

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 714
    

    234 of 238 identical, no gaps.

  10. Islet-like organoids expressing monSTIM1 regulating insulin secretion by light stimulation

    Korea Advanced Institute of Science and Technology

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  11. JP 2023524666-A2023-06-13

    METHODS OF IN VITRO CELL DELIVERY

    INTELLIA THERAPEUTICS INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1651 to 2364. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1651 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1830
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1831 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 2010
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2011 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 2190
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   2191 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2364
    

    234 of 238 identical, no gaps.

  12. DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE

    LIFEEDIT THERAPEUTICS, INC

    Identity 97.9%Family of 5

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||| |||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVP*PTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    233 of 238 identical, no gaps.

    Family of 5

    Grouped by a shared priority claim, US 63/077089.

  13. NUCLEIC ACID CONSTRUCTS FOR SIMULTANEOUS GENE ACTIVATION

    F. HOFFMANN-LA ROCHE AG

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  14. US 11674147-B22023-06-13

    Expression of unfolded protein response proteins improves plant biomass and growth

    Board of Trustees of Michigan State University

    Identity 97.5%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 MGKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| || ||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 VTTFGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| ||||||||||||||||||||||||||| |||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSYQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 714
    

    232 of 238 identical, no gaps.

  15. US 11674156-B22023-06-13

    Adeno-associated virus virion for gene transfer to nervous system cells

    Jichi Medical University

    Identity 97.1%

    Best alignment

    Query 1 to 238, hit 130 to 843. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   130 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 309
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| |||||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   310 VTTFTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 489
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||| ||| ||||||||||||| |||||||||||||
    Hit   490 NRIELKGIDFKEDGNILGHKLEYNYNSHKVYITADKQKNGIKVNFKTRHNIEDGSVQLAD 669
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   670 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 843
    

    231 of 238 identical, no gaps.

  16. JP 2023524976-A2023-06-14

    SELECTION BY ESSENTIAL-GENE KNOCK-IN

    EDITAS MEDICINE INC,BLUEROCK THERAPEUTICS LP

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1864 to 2577. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1864 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 2043
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2044 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 2223
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2224 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 2403
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   2404 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2577
    

    234 of 238 identical, no gaps.

  17. NUCLEIC ACID CONSTRUCTS FOR VA RNA TRANSCRIPTION

    F. HOFFMANN-LA ROCHE AG

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  18. JP 2023525382-A2023-06-15

    MIXER FOR GENERATING PARTICLES

    STEMIRNA THERAPEUTICS CO LTD

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  19. JP 2023525496-A2023-06-16

    ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF

    BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 63/018266.

  20. JP 2023525510-A2023-06-16

    METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PROTEINS

    Cellectis S A

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  21. BACTERIAL MICROCOMPARTMENT VIRUS-LIKE PARTICLES

    National University of Singapore

    Identity 98.7%Family of 2

    Best alignment and family

    Query 1 to 238, hit 40 to 753. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    40 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 219
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   220 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 399
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   400 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 579
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||
    Hit   580 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 753
    

    235 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  22. US 11679127-B22023-06-20

    Antigen binding receptors specific for mutated Fc domains

    Hoffmann-La Roche Inc.

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 1420 to 2133. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1420 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1599
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1600 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1779
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1780 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1959
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1960 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2133
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  23. US 11680267-B22023-06-20

    Co-regulatory sequences based on tetracycline and Cumate

    Shenzhen Eureka Biotechnology Co., Ltd.

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 346 to 1059. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    346 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 525
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    526 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 705
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    706 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 885
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit    886 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1059
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  24. JP 2023526310-A2023-06-21

    COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION

    The Trustees of The University of Pennsylvania

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1980 to 2693. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1980 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 2159
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2160 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 2339
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2340 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 2519
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   2520 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2693
    

    234 of 238 identical, no gaps.

  25. JP 2023526408-A2023-06-21

    VIRAL VECTORS AND NUCLEIC ACIDS FOR REGULATED GENE THERAPY

    Boehringer Ingelheim International GmbH

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 860 to 1573. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    860 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1039
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1040 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1219
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1220 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1399
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1400 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1573
    

    234 of 238 identical, no gaps.

  26. JP 2023526495-A2023-06-21

    SARS-COV-2 VACCINES

    GRITSTONE BIO INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  27. Protein automatic expression system

    Kyungpook National University Industry-Academic Cooperation Foundation

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  28. Salmonella mutant expressing anti-PD-L1 peptide and outer membrane vesicle thereof and pharmaceutical comprising the same

    Kyungpook National University Industry-Academic Cooperation Foundation

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 292 to 1005. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    292 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 471
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    472 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 651
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    652 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 831
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit    832 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1005
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  29. ELOVL2 CONSTRUCTS FOR HUMAN GENE THERAPY

    Visgenx, Inc

    Identity 98.3%Family of 3

    Best alignment and family

    Query 1 to 238, hit 2163 to 2876. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2163 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 2342
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2343 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 2522
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2523 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 2702
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   2703 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2876
    

    234 of 238 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  30. PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT

    THE ASAN FOUNDATION

    Identity 97.9%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||| |||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    233 of 238 identical, no gaps.

  31. CHICKEN ANEMIA VIRUS (CAV)-BASED VECTORS

    FLAGSHIP PIONEERING INNOVATIONS V, INC

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 960 to 1673. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    960 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1139
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1140 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1319
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1320 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1499
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1500 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1673
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. US 11685936-B22023-06-27

    Platform for developing stable mammalian cell lines

    Icosagen Cell Factory OU

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 637 to 1350. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    637 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 816
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    817 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 996
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    997 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1176
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1177 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1350
    

    234 of 238 identical, no gaps.

  33. GENOME ENGINEERING

    President and Fellows of Harvard College

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 2752 to 3465. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2752 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 2931
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2932 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 3111
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   3112 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 3291
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   3292 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 3465
    

    234 of 238 identical, no gaps.

  34. JP 2023528039-A2023-07-03

    ENGINEERED CIRCULAR POLYNUCLEOTIDES

    SHAPE THERAPEUTICS INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  35. JP 2023528476-A2023-07-04

    METHODS FOR STABLE GENOMIC INTEGRATION IN RECOMBINANT MICROORGANISMS

    BIOPLX INC

    Identity 98.7%

    Best alignment

    Query 1 to 238, hit 438 to 1151. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    438 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 617
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||| || ||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    618 VTTFAYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 797
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    798 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 977
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    978 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 1151
    

    235 of 238 identical, no gaps.

  36. US 11692016-B22023-07-04

    High gene expression yeast strain

    Identity 98.3%

    Best alignment

    Query 2 to 238, hit 76 to 786. Positions start at 1 and include both ends.

    Query   2 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 61
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    76 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 255
    
    Query  62 TTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVN 121
              |||||||||||||||||| |||||||||||||||||| ||||||||||||||||||||||
    Hit   256 TTFSYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVN 435
    
    Query 122 RIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH 181
              ||||||||||||||||||||||||||||||| ||||||||| ||||||||||||||||||
    Hit   436 RIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGSVQLADH 615
    
    Query 182 YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   616 YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 786
    

    233 of 237 identical, no gaps.

  37. US 11692192-B22023-07-04

    Anti-microbial and UV-protective extracts and methods of making and using thereof

    BIOCAPITAL HOLDINGS, LLC

    Identity 97.1%Family of 2

    Best alignment and family

    Query 1 to 238, hit 28 to 741. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    28 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 207
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| || ||| ||||||| ||||||||||||||||||||||||||||||||||||||||
    Hit   208 VTTFGYGLQCFARYPDHMKLHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 387
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   388 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 567
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| ||||||||||||||||||||||||||| |||||||
    Hit   568 HYQQNTPIGDGPVLLPDNHYLSYQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 741
    

    231 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  38. US 11692198-B22023-07-04

    Targeted gene activation in plants

    The Regents of the University of California

    Identity 94.9%

    Best alignment

    Query 2 to 238, hit 1 to 711. Positions start at 1 and include both ends.

    Query   2 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 61
              |||||||||||||||||||||||||||| |||||||| ||||||||||||||||||||||
    Hit     1 SKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTLV 180
    
    Query  62 TTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVN 121
              ||  |||||||||||||| |||||||||||||||||| ||||| ||||||||||||||||
    Hit   181 TTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVN 360
    
    Query 122 RIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH 181
              ||||||||||||||||||||||| ||||||| ||||||||| ||||||| ||||||||||
    Hit   361 RIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLADH 540
    
    Query 182 YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||| ||||||||||||||||||||||||||||||||
    Hit   541 YQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 711
    

    225 of 237 identical, no gaps.

  39. JP 2023528715-A2023-07-06

    RNA detection and transcription-dependent editing with reprogrammed tracrRNAs

    Helmholtz-Zentrum fur Infektionsforschung GmbH, Julius-Maximilians-Universitat Wurzburg SFT - Patente und Lizenzen

    Identity 99.1%Family of 2

    Best alignment and family

    Query 6 to 229, hit 4 to 675. Positions start at 1 and include both ends.

    Query   6 ELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFS 65
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 ELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLT 183
    
    Query  66 YGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIEL 125
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 YGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIEL 363
    
    Query 126 KGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQN 185
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 KGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQN 543
    
    Query 186 TPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGI 229
              ||||||||||||||||||||||||||||||||||||||||||||
    Hit   544 TPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGI 675
    

    222 of 224 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, EP 20160004.6.

  40. SAFE HARBOR LOCI

    ARSENAL BIOSCIENCES, INC

    Identity 97.9%

    Best alignment

    Query 1 to 238, hit 520 to 1233. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    520 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 699
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    700 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 879
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    880 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1059
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               ||||||||||||||||||||||||| |||||||||||||||||||||||| |||||||
    Hit   1060 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1233
    

    233 of 238 identical, no gaps.

  41. WO 2023127907-A2023-07-06

    An agent for avoiding an immune responce of transgenic cells

    Hyperion Drug Discovery Co., Ltd

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  42. A conjugate of poly GLP1 variant

    PROABTECH INC.

    Identity 94.8%

    Best alignment

    Query 5 to 236, hit 40 to 735. Positions start at 1 and include both ends.

    Query   5 EELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTF 64
              ||||||||||||||||||||||||| |||||||| ||||||||||||||||||||||||
    Hit    40 EELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTLVTTL 219
    
    Query  65 SYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIE 124
               |||||||||||||| |||||||||||||||||| ||||| |||||||||||||||||||
    Hit   220 TYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVNRIE 399
    
    Query 125 LKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQ 184
              |||||||||||||||||||| ||||||| ||||||||| ||||||| |||||||||||||
    Hit   400 LKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLADHYQQ 579
    
    Query 185 NTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDEL 236
              ||||||||||||||||||||| ||||||||||||||||||||||||||||||
    Hit   580 NTPIGDGPVLLPDNHYLSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDEL 735
    

    220 of 232 identical, no gaps.

  43. JP 2023098806-A2023-07-11

    Purification method of adeno-associated virus

    TOSOH corporation

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 10 to 723. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    10 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 189
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   190 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 369
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   370 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 549
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   550 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 723
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  44. US 11697825-B22023-07-11

    Compositions and methods for the production of scAAV

    Voyager Therapeutics, Inc.

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1169 to 1882. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1169 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1348
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1349 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1528
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1529 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1708
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1709 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1882
    

    234 of 238 identical, no gaps.

  45. JP 2023529833-A2023-07-12

    ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN INHIBITORY NEOCORTICAL NEURONS

    Allen Institute

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 63/034794.

  46. US 11702644-B22023-07-18

    Methods and compositions for in vivo gene editing based cell-type-specific cellular engineering

    California Institute of Technology

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 184 to 897. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 363
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 543
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   544 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 723
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   724 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 897
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  47. US 11702658-B22023-07-18

    Methods and compositions for editing RNAs

    EDIGENE THERAPEUTICS (BEIJING) INC. and PEKING UNIVERSITY

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 714
    

    234 of 238 identical, no gaps.

  48. US 11702661-B22023-07-18

    Constructs for continuous monitoring of live cells

    The Broad Institute, Inc. and Massachusetts Institute of Technology

    Identity 97.9%

    Best alignment

    Query 2 to 238, hit 1 to 711. Positions start at 1 and include both ends.

    Query   2 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 61
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 180
    
    Query  62 TTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVN 121
              ||| || ||| |||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TTFGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVN 360
    
    Query 122 RIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH 181
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 RIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH 540
    
    Query 182 YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||| ||||||||||||||||||||||||||| |||||||
    Hit   541 YQQNTPIGDGPVLLPDNHYLSYQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 711
    

    232 of 237 identical, no gaps.

  49. US 11702766-B22023-07-18

    Systematic creation of fluorescent fusion polypeptides

    Identity 94.9%

    Best alignment

    Query 5 to 238, hit 400 to 1101. Positions start at 1 and include both ends.

    Query    5 EELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTF 64
               ||||||||||||||||||||||||| |||||||| ||||||||||||||||||||||||
    Hit    400 EELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTLVTTL 579
    
    Query   65 SYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIE 124
                |||||||||||||| |||||||||||||||||| ||||| |||||||||||||||||||
    Hit    580 TYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVNRIE 759
    
    Query  125 LKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQ 184
               |||||||||||||||||||| ||||||| ||||||||| ||||||| |||||||||||||
    Hit    760 LKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLADHYQQ 939
    
    Query  185 NTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               ||||||||||||||||||||| ||||||||||||||||||||||||||||||||
    Hit    940 NTPIGDGPVLLPDNHYLSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 1101
    

    222 of 234 identical, no gaps.

  50. US 11708396-B22023-07-25

    Signal-sensor polynucleotides for the alteration of cellular phenotypes

    ModernaTX, Inc.

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 51 to 764. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    51 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 230
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   231 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 410
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   411 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 590
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   591 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 764
    

    234 of 238 identical, no gaps.